NCT02017236View on ClinicalTrials.gov

A Food Effect Phase I Study of the Volitinib in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

June 30, 2014

Conditions
Food EffectHealth Subjects
Interventions
DRUG

Volitinib

600mg Volitinib ,single dose,oral

Trial Locations (1)

200031

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors
lead

Hutchison Medipharma Limited

INDUSTRY

NCT02017236 - A Food Effect Phase I Study of the Volitinib in Healthy Subjects | Biotech Hunter | Biotech Hunter